Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..
1999.
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..
1997.
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.